SCD and lung cancer: Some small molecule SCD inhibitors have been found to have obvious anti-tumor effects, including BZ36, A939572, CAY10566, MF-438 and CVT-11127, etc. These drugs have shown great potential to suppress cancer in colorectal cancer, renal cell carcinoma, lung cancer, BC and other cancers [114,196–198].